Skip to content

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.

Randomized controlled trial · Sci Rep · 2017. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 28916821

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.

Cavedo E, Grothe MJ, Colliot O et al.
Sci Rep · 2017

PubMed ID
28916821
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.